Free shipping on all orders over $ 500

R-7050

Cat. No. M8516

All AbMole products are for research use only, cannot be used for human consumption.

R-7050 Structure
Synonym:

TNF-α Antagonist III; R7050

Size Price Availability Quantity
10mM*1mL in DMSO USD 60 In stock
5mg USD 60 In stock
10mg USD 90 In stock
25mg USD 210 In stock
50mg USD 290 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

R-7050 is a cell-permeable TNF-α receptor antagonist that blocks TNF-α-induced binding of TNF-αRI with TNFαR-associated death domain protein and receptor interacting protein 1, blocking internalization of the TNFα-TNFαR complex. R-7050 was found to reduce neurovascular injury in a mouse model of hemorrhagic stroke.

R-7050 (TNF-α Antagonist III) (6 mg/kg) reduces Evans blue extravasation to 28.7±5.9 μg and 30.3±1.9 μg Evans blue/g brain tissue when administered at 0.5 h or 2 h post-ICH, respectively (p<0.05 and p<0.01 vs ICH, respectively; not significantly different from sham). Brain water content, a measure of brain edema, increases from 75.6±0.3% in sham-operated mice to 81.5±0.5% at 24h post-ICH (p<0.05 vs. sham).

Chemical Information
Molecular Weight 380.77
Formula C16H8ClF3N4S
CAS Number 303997-35-5
Solubility (25°C) DMSO 20 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Min Ji, et al. Microglia-derived TNF-α mediates Müller cell activation by activating the TNFR1-NF-κB pathway

[2] Shih-Yi Lin, et al. TNF-α Receptor Inhibitor Alleviates Metabolic and Inflammatory Changes in a Rat Model of Ischemic Stroke

[3] Tolulope E Ayo, et al. TNF Production in Activated RBL-2H3 Cells Requires Munc13-4

[4] Yi Wen, et al. KLF4 in Macrophages Attenuates TNF α-Mediated Kidney Injury and Fibrosis

[5] Melanie D King, et al. TNF-alpha receptor antagonist, R-7050, improves neurological outcomes following intracerebral hemorrhage in mice

Related TNF Receptor Products
Lenalidomide

Lenalidomide is a thalidomide analog known to display TNF-α secretion inhibition and possesses immunomodulatory properties.

Atrosab

Atrosab is a humanized IgG1 antagonistic anti-TNFR1 antibody. Atrosab inhibits TNF-mediated Apoptosis induction and IL-6 and IL-8 production. Atrosab reduces neurological deficits.

Infliximab

Infliximab is a purified, recombinant DNA-derived chimeric human-mouse IgG monoclonal antibody that blocks TNF-α interaction with TNF-α receptor 1 (TNFR1) and TNFR2. For the treatment of autoimmune diseases. Infliximab is available in BALB/ C or C57/Bl6 mice.

Mesaconitine

Mesaconitine is the main active ingredient of Aconitum and has many pharmaceutical effects.

Hypaconitine

Hypaconitine is a highly toxic natural active ingredient isolated from aconitum species, which is widely used to study rheumatism.

  Catalog
Abmole Inhibitor Catalog




Keywords: R-7050, TNF-α Antagonist III; R7050 supplier, TNF Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.